Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
13.71
+0.38 (2.85%)
At close: Jan 21, 2026, 4:00 PM EST
13.74
+0.03 (0.22%)
After-hours: Jan 21, 2026, 4:46 PM EST
Amneal Pharmaceuticals Employees
Amneal Pharmaceuticals had 8,300 employees as of December 31, 2024. The number of employees increased by 450 or 5.73% compared to the previous year.
Employees
8,300
Change (1Y)
450
Growth (1Y)
5.73%
Revenue / Employee
$353,610
Profits / Employee
$711
Market Cap
4.31B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 8,300 | 450 | 5.73% |
| Dec 31, 2023 | 7,850 | 250 | 3.29% |
| Dec 31, 2022 | 7,600 | 600 | 8.57% |
| Dec 31, 2021 | 7,000 | 1,000 | 16.67% |
| Dec 31, 2020 | 6,000 | 500 | 9.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch Health Companies | 20,700 |
| Perrigo Company | 8,379 |
| HUTCHMED (China) | 1,811 |
| Alkermes | 1,800 |
| Hims & Hers Health | 1,637 |
| Indivior | 1,051 |
| Lantheus Holdings | 808 |
| Supernus Pharmaceuticals | 674 |
AMRX News
- 7 days ago - Amneal Pharmaceuticals, Inc. (AMRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 12 days ago - KeifeRx Announces Research Collaboration and Option Agreement with Amneal Pharmaceuticals to Advance KFRX06, a Brain-Penetrant LRRK2 Program for Parkinson's Disease - Business Wire
- 4 weeks ago - Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA® - GlobeNewsWire
- 4 weeks ago - Amneal: Growing Drug Portfolio, Positive Cash Flow, Outweighing Leverage Risks - Seeking Alpha
- 6 weeks ago - Amneal Receives U.S. FDA Approval for Epinephrine Injection in Single- and Multi-Dose Vials for U.S. Hospitals - GlobeNewsWire
- 6 weeks ago - Amneal Announces Positive Interim Phase 4 ELEVATE-PD Results With CREXONT® for Parkinson's Disease - GlobeNewsWire
- 7 weeks ago - Amneal Receives U.S. FDA Approval for Albuterol Sulfate Inhalation Aerosol - GlobeNewsWire
- 7 weeks ago - Amneal to Participate in Upcoming Investor Conferences - GlobeNewsWire